<DOC>
	<DOCNO>NCT01312701</DOCNO>
	<brief_summary>Tumors systemic immune modify effect . They affect immune system similarly state chronic inflammation effect : - monitor analysis nk myeloid cell mainly study zeta chain also mean - may decrease follow effective anticancer therapy - may even use study effectiveness anticancer therapy - important monitor investigator plan formulation systemic immune therapy Thus immumonitoring systemic blood cell may turn important prognostic predictive factor many cancer type</brief_summary>
	<brief_title>Study Blood Immune Cells Cancer Patients Compared Controls</brief_title>
	<detailed_description>CD247 Known also zeta chain important relay T-cell induced signal transduction . Interestingly study Baniash others demonstrate chain regulated state chronic inflammation cancer peripheral blood T cell also NK cell However prospective study marker cancer control patient study reveal level CD247 immune cell cancer patient compare control may reveal effect anticancer therapy CD247 cancer patient study may contribute significantly ability monitor systemic immune system characteristic cancer patient help study immunomodulation vaccination scheme patient</detailed_description>
	<criteria>patient cancer blood donators agree participate trial disease state may cause chronic inflammation</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>cancer</keyword>
	<keyword>immunomonitoring</keyword>
	<keyword>CD247 -zeta chain</keyword>
	<keyword>chronic inflamation</keyword>
	<keyword>anticancertherapy</keyword>
</DOC>